Midway launches b4 hand sanitizer, pledges to donate half of profits to children’s charities
HOUSTON — In an effort to help parents combat germs that children may come in contact with on airline tray tables, public bathrooms, hotel remotes, touch screen kiosks and more, Midway developed a highly effective germ-fighting hand sanitizer and packaged the gel — called b4 — in small, single-use packets that are easy to carry in a wallet, pocket or small purse.
While the bold gel packet colors are fun for children and adults, the real b4 bonus comes down to charity — 50% of profits from the sale of b4 go toward children-focused causes.
"We realized during the economic downturn a few years ago that when money is tight, so is charitable giving," stated Jonathan Brinsden, CEO of Midway. "We saw funds dry up at many local charities supported through our Midway Foundation, and we felt the need to create a revenue source for charity through a product people will always have a need to use."
To date, The Midway Foundation has donated more than $1.2 million to more than 150 organizations.
The b4 hand sanitizer packets are sold in a 25-count box, 50-count box, an 8-oz. pump bottle and a five-count blister pack. Boxes are sold online for $3 for the blister pack, $3.99 for a 25-count box to $5.99 for a 50-count box, while the pump bottle retails for $3.50.
UCLA researchers employ Google Glass app as disease diagnostics tool
LOS ANGELES — A team of researchers from UCLA’s Henry Samueli School of Engineering and Applied Science has developed a Google Glass application and a server platform that allow users of the wearable, glasses-like computer to perform instant, wireless diagnostic testing for a variety of diseases and health conditions.
With the new UCLA technology, Google Glass wearers can use the device’s hands-free camera to capture pictures of rapid diagnostic tests, small strips on which blood or fluid samples are placed and which change color to indicate the presence of HIV, malaria, prostate cancer or other conditions. Without relying on any additional devices, users can upload these images to a UCLA-designed server platform and receive accurate analyses — far more detailed than with the human eye — in as little as eight seconds.
According to the group, the new technology could enhance the tracking of diseases and improve public health monitoring and rapid responses in disaster-relief areas or quarantine zones where conventional medical tools are not available or feasible, the researchers said.
"This breakthrough technology takes advantage of gains in both immunochromatographic rapid diagnostic tests and wearable computers," stated principal investigator Aydogan Ozcan, the Chancellor’s Professor of Electrical Engineering and Bioengineering at UCLA and associate director of UCLA’s California NanoSystems Institute. "This smart app allows for real-time tracking of health conditions and could be quite valuable in epidemiology, mobile health and telemedicine."
The research is published online in the peer-reviewed journal ACS Nano.
BioElectronics, supplier of pain relief products, initiates consumer awareness program
FREDERICK, Md. — BioElectronics, maker of consumer medical devices and drug-free pain therapies, earlier this week announced that it is participating in upcoming consumer educational events and programs as part of an international campaign to discuss alternative pain modalities.
BioElectronics is participating in “Take Control of Your Pain” day sponsored by the U.S. Pain Foundation on March 9 at the Phoenix Convention Center. Mac Stein, a registered physical therapist, will answer questions and provide information about drug-free treatment of injuries and chronic pain.
“Consumers should know that physical therapy, especially when augmented with pain-relief devices like those made by BioElectronics can provide significant relief by quickly minimizing pain and reducing swelling," Stein said. "ActiPatch seamlessly integrates with most pain-management programs.”
ActiPatch was recently picked up for distribution by Boots in the United Kingdom. “ActiPatch brings real innovation to both consumers and customers," stated Paul Screawn, director of GRO-International, European Brand Managers. “The innovation and the consumer benefits of long lasting, safe and affordable pain relief gained the interest of the Boots team. Their input and guidance has been invaluable in ensuring the brand is relevantly positioned to grow in the United Kingdom and broader European markets."
Additional upcoming installments of BioElectronics educational program on Google Plus News, “Get Out of Pain,” will feature a panel of medical experts providing consumer-level education highlighting drug-free pain treatment.